PepGen Inc. (PEPG)
2.42
+0.10
(+4.31%)
USD |
NASDAQ |
Nov 06, 15:22
PepGen Net Income (TTM) : -71.94M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -71.94M |
| March 31, 2026 | -77.22M |
| December 31, 2025 | -89.66M |
| September 30, 2025 | -93.56M |
| June 30, 2025 | -96.92M |
| March 31, 2025 | -102.16M |
| December 31, 2024 | -89.98M |
| September 30, 2024 | -87.23M |
| June 30, 2024 | -89.14M |
| March 31, 2024 | -80.33M |
| Date | Value |
|---|---|
| December 31, 2023 | -78.63M |
| September 30, 2023 | -74.07M |
| June 30, 2023 | -69.38M |
| March 31, 2023 | -67.18M |
| December 31, 2022 | -69.10M |
| September 30, 2022 | -61.31M |
| June 30, 2022 | -50.82M |
| March 31, 2022 | -40.14M |
| December 31, 2021 | -22.69M |
| September 30, 2021 | -15.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Korsana Biosciences, Inc. | -6.707M |
| IRulya Therapeutics, Inc. | -92.48M |
| Q32 Bio, Inc. | 32.25M |
| Bridgebio Oncology Therapeutics, Inc. | -182.11M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |